India To Set Lower Margin For MNC Drugs With Local Alternative
This article was originally published in PharmAsia News
Executive Summary
India's regulators plan to limit the ability of multinational drug makers to price their drugs in India if local alternatives are available. The government already is checking on that availability before approving the price of imported brand drugs. If a local alternative is available, the plan is to allow the foreign maker lower margins as a percentage of the landed cost, along with the therapeutic value and the drug's relationship to the quality of life. The government appears united on that aspect of price controls as its chief regulators continue to argue over a new policy. (Click here for more